Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2024-04-16 13:08 Tx date 2024-04-15 |
$GENX
Genix Pharmaceuticals Corporation |
Pirooz, Sina
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-9,360
-144,000 vol $0.065 each |
891,300 | |
Filed 2024-04-16 13:07 Tx date 2024-04-15 |
$GENX
Genix Pharmaceuticals Corporation |
Pirooz, Sina
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-110.50
-1,700 vol $0.065 each |
1,035,300 | |
Filed 2024-03-27 12:49 Tx date 2024-03-22 |
$GENX
Genix Pharmaceuticals Corporation |
Pirooz, Sina
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-30,225
-403,000 vol $0.075 each |
1,037,000 | |
Filed 2023-12-28 14:18 Tx date 2023-12-27 |
$GENX
Genix Pharmaceuticals Corporation |
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$740.00
+37,000 vol $0.02 each |
10,501,110 | |
Filed 2023-12-20 12:31 Tx date 2023-12-18 |
$GENX
Genix Pharmaceuticals Corporation |
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,250
+150,000 vol $0.035 each |
10,464,110 | |
Filed 2023-07-02 16:49 Tx date 2023-06-28 |
$GENX
Genix Pharmaceuticals Corporation |
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$605.00
+11,000 vol $0.055 each |
10,244,110 | |
Filed 2023-07-02 16:47 Tx date 2023-06-28 |
$GENX
Genix Pharmaceuticals Corporation |
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,780
+70,000 vol $0.054 each |
10,314,110 | |
Filed 2023-06-29 19:05 Tx date 2023-06-28 |
$GENX
Genix Pharmaceuticals Corporation |
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,355
+61,000 vol $0.055 each |
||
Filed 2023-06-29 19:04 Tx date 2023-06-28 |
$GENX
Genix Pharmaceuticals Corporation |
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,000
+20,000 vol $0.05 each |
||
Filed 2023-06-29 19:05 Tx date 2023-06-28 |
$GENX
Genix Pharmaceuticals Corporation |
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,355
+61,000 vol $0.055 each |
10,314,110 | |
Filed 2023-06-29 19:04 Tx date 2023-06-28 |
$GENX
Genix Pharmaceuticals Corporation |
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,000
+20,000 vol $0.05 each |
10,253,110 | |
Filed 2023-06-21 21:29 Tx date 2021-03-22 |
$GENX
Genix Pharmaceuticals Corporation |
Pirooz, Sina
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$6,000
+50,000 vol $0.12 each |
350,000 | |
Filed 2023-06-21 21:29 Tx date 2020-08-10 |
$GENX
Genix Pharmaceuticals Corporation |
Pirooz, Sina
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$36,000
+300,000 vol $0.12 each |
300,000 | |
Filed 2023-06-21 21:27 Tx date 2020-08-06 |
$GENX
Genix Pharmaceuticals Corporation |
Bottomley, Kevin
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$36,000
+300,000 vol $0.12 each |
300,000 | |
Filed 2023-06-21 21:27 Tx date 2021-03-22 |
$GENX
Genix Pharmaceuticals Corporation |
Bottomley, Kevin
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$6,000
+50,000 vol $0.12 each |
350,000 | |
Filed 2023-06-21 21:25 Tx date 2021-03-22 |
$GENX
Genix Pharmaceuticals Corporation |
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$120,000
+1,000,000 vol $0.12 each |
1,000,000 | |
Filed 2021-03-23 19:26 Tx date 2021-03-22 |
$GENX
Genix Pharmaceuticals Corporation |
Pirooz, Sina
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$15,000
+50,000 vol $0.30 each |
||
Filed 2021-03-23 11:03 Tx date 2021-03-22 |
$GENX
Genix Pharmaceuticals Corporation |
Bottomley, Kevin
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$15,000
+50,000 vol $0.30 each |
||
Filed 2021-03-23 11:01 Tx date 2021-03-22 |
$GENX
Genix Pharmaceuticals Corporation |
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$300,000
+1,000,000 vol $0.30 each |
||
Filed 2020-08-13 18:13 Tx date 2020-08-06 |
$GENX
Genix Pharmaceuticals Corporation |
Bottomley, Kevin
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$90,000
+300,000 vol $0.30 each |
||
Filed 2020-08-12 14:35 Tx date 2020-08-10 |
$GENX
Genix Pharmaceuticals Corporation |
Pirooz, Sina
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$90,000
+300,000 vol $0.30 each |
||
Filed 2022-10-03 15:15 Tx date 2022-09-30 |
$GENX
Genix Pharmaceuticals Corporation |
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$80.00
+1,000 vol $0.08 each |
10,233,110 | |
Filed 2022-09-28 10:31 Tx date 2022-09-27 |
$GENX
Genix Pharmaceuticals Corporation |
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$720.00
+9,000 vol $0.08 each |
10,232,110 | |
Filed 2022-08-30 22:15 Tx date 2022-08-29 |
$GENX
Genix Pharmaceuticals Corporation |
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$330.00
+3,000 vol $0.11 each |
10,223,110 | |
Filed 2022-08-25 22:25 Tx date 2022-08-24 |
$GENX
Genix Pharmaceuticals Corporation |
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$110.00
+1,000 vol $0.11 each |
10,220,110 | |
Filed 2022-04-08 11:45 Tx date 2021-05-19 |
$GENX
Genix Pharmaceuticals Corporation |
Mahmoud, Aziz
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
6,419,671 | ||
Filed 2022-04-08 11:35 Tx date 2021-05-19 |
$GENX
Genix Pharmaceuticals Corporation |
Mahmoud, Aziz
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-04-08 11:34 Tx date 2021-05-19 |
$GENX
Genix Pharmaceuticals Corporation |
Mahmoud, Aziz
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
1,400,000 | ||
Filed 2022-01-27 17:26 Tx date 2021-04-28 |
$GENX
Genix Pharmaceuticals Corporation |
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,300
+30,000 vol $0.21 each |
9,631,110 | |
Filed 2021-04-29 16:48 Tx date 2021-04-28 |
$GENX
Genix Pharmaceuticals Corporation |
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,500
+50,000 vol $0.21 each |
||
Filed 2022-01-18 12:10 Tx date 2022-01-17 |
$GENX
Genix Pharmaceuticals Corporation |
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$12,500
+100,000 vol $0.125 each |
10,239,110 | |
Filed 2021-12-24 18:08 Tx date 2021-12-24 |
$GENX
Genix Pharmaceuticals Corporation |
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,570
+34,000 vol $0.105 each |
10,139,110 | |
Filed 2021-12-23 16:10 Tx date 2021-12-22 |
$GENX
Genix Pharmaceuticals Corporation |
Pirooz, Sina
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-9,742.81
-88,571 vol $0.11 each |
1,440,000 | |
Filed 2021-12-21 19:30 Tx date 2021-12-03 |
$GENX
Genix Pharmaceuticals Corporation |
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,800
+20,000 vol $0.14 each |
10,105,110 | |
Filed 2021-12-21 19:30 Tx date 2021-12-03 |
$GENX
Genix Pharmaceuticals Corporation |
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,990
+23,000 vol $0.13 each |
10,085,110 | |
Filed 2021-11-12 11:49 Tx date 2021-11-11 |
$GENX
Genix Pharmaceuticals Corporation |
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,300
+20,000 vol $0.165 each |
10,062,110 | |
Filed 2021-11-04 14:09 Tx date 2021-11-02 |
$GENX
Genix Pharmaceuticals Corporation |
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,400
+16,000 vol $0.15 each |
10,042,110 | |
Filed 2021-10-18 13:58 Tx date 2021-10-15 |
$GENX
Genix Pharmaceuticals Corporation |
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$85.00
+500 vol $0.17 each |
10,026,110 | |
Filed 2021-10-13 16:28 Tx date 2021-10-13 |
$GENX
Genix Pharmaceuticals Corporation |
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,165
+24,500 vol $0.17 each |
10,025,610 | |
Filed 2021-09-24 16:10 Tx date 2021-09-24 |
$GENX
Genix Pharmaceuticals Corporation |
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,150
+17,500 vol $0.18 each |
10,001,110 | |
Filed 2021-09-24 16:08 Tx date 2021-09-24 |
$GENX
Genix Pharmaceuticals Corporation |
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,187
+12,500 vol $0.175 each |
9,983,610 | |
Filed 2021-09-10 20:02 Tx date 2021-09-08 |
$GENX
Genix Pharmaceuticals Corporation |
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,200
+40,000 vol $0.18 each |
9,971,110 | |
Filed 2021-09-01 15:32 Tx date 2021-08-31 |
$GENX
Genix Pharmaceuticals Corporation |
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,800
+20,000 vol $0.19 each |
9,931,110 | |
Filed 2021-08-27 11:13 Tx date 2021-08-26 |
$GENX
Genix Pharmaceuticals Corporation |
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,000
+10,000 vol $0.20 each |
9,911,110 | |
Filed 2021-08-18 17:03 Tx date 2021-08-18 |
$GENX
Genix Pharmaceuticals Corporation |
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,920
+44,000 vol $0.18 each |
9,901,110 | |
Filed 2021-08-18 12:07 Tx date 2021-08-17 |
$GENX
Genix Pharmaceuticals Corporation |
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,780
+21,000 vol $0.18 each |
9,857,110 | |
Filed 2021-08-12 12:11 Tx date 2021-08-10 |
$GENX
Genix Pharmaceuticals Corporation |
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,535
+13,000 vol $0.195 each |
9,836,110 | |
Filed 2021-08-12 12:10 Tx date 2021-08-10 |
$GENX
Genix Pharmaceuticals Corporation |
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,400
+22,000 vol $0.20 each |
9,823,110 | |
Filed 2021-08-09 15:44 Tx date 2021-08-06 |
$GENX
Genix Pharmaceuticals Corporation |
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,700
+30,000 vol $0.19 each |
9,801,110 | |
Filed 2021-08-09 15:43 Tx date 2021-08-05 |
$GENX
Genix Pharmaceuticals Corporation |
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,710
+9,000 vol $0.19 each |
9,771,110 | |
Filed 2021-07-30 11:37 Tx date 2021-07-29 |
$GENX
Genix Pharmaceuticals Corporation |
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$190.00
+1,000 vol $0.19 each |
9,762,110 | |
Filed 2021-07-30 11:32 Tx date 2021-07-29 |
$GENX
Genix Pharmaceuticals Corporation |
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$600.00
+3,000 vol $0.20 each |
9,761,110 | |
Filed 2021-07-29 11:57 Tx date 2021-07-28 |
$GENX
Genix Pharmaceuticals Corporation |
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,400
+7,000 vol $0.20 each |
9,758,110 | |
Filed 2021-06-25 18:01 Tx date 2021-06-25 |
$GENX
Genix Pharmaceuticals Corporation |
Lewin, Jamie A.
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-30,000
-150,000 vol $0.20 each |
0 | |
Filed 2021-05-21 11:29 Tx date 2021-05-20 |
$GENX
Genix Pharmaceuticals Corporation |
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,250
+25,000 vol $0.21 each |
9,751,110 | |
Filed 2021-05-17 12:42 Tx date 2021-05-17 |
$GENX
Genix Pharmaceuticals Corporation |
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$15,750
+75,000 vol $0.21 each |
9,726,110 | |
Filed 2021-04-29 16:48 Tx date 2021-04-28 |
$GENX
Genix Pharmaceuticals Corporation |
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,500
+50,000 vol $0.21 each |
9,651,110 | |
Filed 2021-04-12 10:38 Tx date 2018-08-27 |
$GENX
Genix Pharmaceuticals Corporation |
Pirooz, Sina
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2020-08-12 14:16 Tx date 2018-08-27 |
$GENX
Genix Pharmaceuticals Corporation |
Pirooz, Sina
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-03-25 12:35 Tx date 2021-03-22 |
$GENX
Genix Pharmaceuticals Corporation |
Lee, Danny Wayne Kent
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$90,000
+300,000 vol $0.30 each |
700,000 | |
Filed 2021-03-23 19:26 Tx date 2021-03-22 |
$GENX
Genix Pharmaceuticals Corporation |
Pirooz, Sina
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$15,000
+50,000 vol $0.30 each |
1,878,571 | |
Filed 2021-03-23 11:03 Tx date 2021-03-22 |
$GENX
Genix Pharmaceuticals Corporation |
Bottomley, Kevin
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$15,000
+50,000 vol $0.30 each |
350,000 | |
Filed 2021-03-23 11:01 Tx date 2021-03-22 |
$GENX
Genix Pharmaceuticals Corporation |
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$300,000
+1,000,000 vol $0.30 each |
1,000,000 | |
Filed 2021-03-23 11:00 Tx date 2020-12-30 |
$GENX
Genix Pharmaceuticals Corporation |
Chow, Paul
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-03-22 13:09 Tx date 2021-03-22 |
$GENX
Genix Pharmaceuticals Corporation |
Yea, Darryl
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$240,000
+800,000 vol $0.30 each |
1,100,000 | |
Filed 2021-02-04 13:34 Tx date 2021-01-29 |
$GENX
Genix Pharmaceuticals Corporation |
Lewin, Jamie A.
4 - Director of Issuer
Direct Ownership
|
Common Shares
46 - Compensation for services
|
$36,000
+150,000 vol $0.24 each |
150,000 | |
Filed 2021-02-04 13:29 Tx date 2019-03-11 |
$GENX
Genix Pharmaceuticals Corporation |
Lewin, Jamie A.
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2020-12-31 16:40 Tx date 2020-12-30 |
$GENX
Genix Pharmaceuticals Corporation |
Chow, Paul
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$340,086
+6,801,737 vol $0.05 each |
9,601,110 | |
Filed 2020-12-31 16:38 Tx date 2020-12-30 |
$GENX
Genix Pharmaceuticals Corporation |
Chow, Paul
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
2,799,373 | ||
Filed 2020-12-23 17:43 Tx date 2020-12-14 |
$GENX
Genix Pharmaceuticals Corporation |
Lee, Danny Wayne Kent
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$88,000
+400,000 vol $0.22 each |
400,000 | |
Filed 2020-12-23 17:41 Tx date 2020-12-14 |
$GENX
Genix Pharmaceuticals Corporation |
Lee, Danny Wayne Kent
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2020-09-21 19:39 Tx date 2020-09-18 |
$GENX
Genix Pharmaceuticals Corporation |
Yea, Darryl
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$90,000
+300,000 vol $0.30 each |
300,000 | |
Filed 2020-09-21 19:36 Tx date 2020-09-18 |
$GENX
Genix Pharmaceuticals Corporation |
Yea, Darryl
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2020-09-21 19:32 Tx date 2020-09-18 |
$GENX
Genix Pharmaceuticals Corporation |
Yea, Darryl
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2020-09-21 19:29 Tx date 2020-09-18 |
$GENX
Genix Pharmaceuticals Corporation |
Yea, Darryl
4 - Director of Issuer
Holder: Investco Capital Management (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
500,000 | ||
Filed 2020-08-13 18:13 Tx date 2020-08-06 |
$GENX
Genix Pharmaceuticals Corporation |
Bottomley, Kevin
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$90,000
+300,000 vol $0.30 each |
300,000 | |
Filed 2020-08-13 18:11 Tx date 2019-08-01 |
$GENX
Genix Pharmaceuticals Corporation |
Bottomley, Kevin
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2020-08-13 14:16 Tx date 2020-07-03 |
$GENX
Genix Pharmaceuticals Corporation |
Lewin, Jamie A.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+450,000 vol |
450,000 | |
Filed 2020-08-13 14:12 Tx date 2019-03-11 |
$GENX
Genix Pharmaceuticals Corporation |
Lewin, Jamie A.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2020-08-12 14:35 Tx date 2020-08-10 |
$GENX
Genix Pharmaceuticals Corporation |
Pirooz, Sina
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$90,000
+300,000 vol $0.30 each |
1,828,571 | |
Filed 2020-08-12 14:16 Tx date 2018-08-27 |
$GENX
Genix Pharmaceuticals Corporation |
Pirooz, Sina
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
1,528,571 | ||
Filed 2020-07-23 12:32 Tx date 2020-07-21 |
$GENX
Genix Pharmaceuticals Corporation |
Pirooz, Sina
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$21,000
+100,000 vol $0.21 each |
1,528,571 | |
Filed 2020-07-23 12:32 Tx date 2020-07-21 |
$GENX
Genix Pharmaceuticals Corporation |
Pirooz, Sina
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$-210,000
-1,000,000 vol $0.21 each |
1,428,571 | |
Filed 2020-07-23 12:29 Tx date 2020-07-21 |
$GENX
Genix Pharmaceuticals Corporation |
Pirooz, Sina
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$210,000
+1,000,000 vol $0.21 each |
2,428,571 | |
Filed 2020-07-23 12:27 Tx date 2018-08-27 |
$GENX
Genix Pharmaceuticals Corporation |
Pirooz, Sina
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
1,428,571 | ||
Filed 2020-01-22 17:20 Tx date 2020-01-22 |
$GENX
Genix Pharmaceucticals Corporation |
Bottomley, Kevin
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$400.00
+5,000 vol $0.08 each |
5,000 | |
Filed 2020-01-22 17:20 Tx date 2019-08-01 |
$GENX
Genix Pharmaceucticals Corporation |
Bottomley, Kevin
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|